213 related articles for article (PubMed ID: 8566118)
1. Effects of the non-peptide inhibitor OPC-21268 on oxytocin and vasopressin stimulation of rat and human myometrium.
Atke A; Vilhardt H; Hauzerova L; Barth T; Andersen LF
Eur J Pharmacol; 1995 Jul; 281(1):63-8. PubMed ID: 8566118
[TBL] [Abstract][Full Text] [Related]
2. Receptors for and myometrial responses to oxytocin and vasopressin in preterm and term human pregnancy: effects of the oxytocin antagonist atosiban.
Bossmar T; Akerlund M; Fantoni G; Szamatowicz J; Melin P; Maggi M
Am J Obstet Gynecol; 1994 Dec; 171(6):1634-42. PubMed ID: 7802081
[TBL] [Abstract][Full Text] [Related]
3. Effects of an orally active vasopressin V1 receptor antagonist.
Burrell LM; Phillips PA; Stephenson J; Risvanis J; Hutchins AM; Johnston CI
Clin Exp Pharmacol Physiol; 1993 May; 20(5):388-91. PubMed ID: 8391950
[TBL] [Abstract][Full Text] [Related]
4. Spontaneous contractions of myometrium from humans, non-human primate and rodents are sensitive to selective oxytocin receptor antagonism in vitro.
Wilson RJ; Allen MJ; Nandi M; Giles H; Thornton S
BJOG; 2001 Sep; 108(9):960-6. PubMed ID: 11563467
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a novel non-peptide vasopressin V1 receptor antagonist (OPC-21268) in the rat.
Burrell LM; Phillips PA; Stephenson J; Risvanis J; Hutchins AM; Johnston CI
J Endocrinol; 1993 Aug; 138(2):259-66. PubMed ID: 8228734
[TBL] [Abstract][Full Text] [Related]
6. Vasopressin-induced contraction of uterus is mediated solely by the oxytocin receptor in mice, but not in humans.
Kawamata M; Mitsui-Saito M; Kimura T; Takayanagi Y; Yanagisawa T; Nishimori K
Eur J Pharmacol; 2003 Jul; 472(3):229-34. PubMed ID: 12871758
[TBL] [Abstract][Full Text] [Related]
7. Conformational aspects of differences in requirements for oxytocin and vasopressin receptors.
Oldziej S; Ciarkowski J; Liwo A; Shenderovich MD; Grzonka Z
J Recept Signal Transduct Res; 1995; 15(1-4):703-13. PubMed ID: 8903974
[TBL] [Abstract][Full Text] [Related]
8. Human myometrium during pregnancy contains and responds to V1 vasopressin receptors as well as oxytocin receptors.
Maggi M; Del Carlo P; Fantoni G; Giannini S; Torrisi C; Casparis D; Massi G; Serio M
J Clin Endocrinol Metab; 1990 Apr; 70(4):1142-54. PubMed ID: 2156888
[TBL] [Abstract][Full Text] [Related]
9. Receptor binding of oxytocin and vasopressin antagonists and inhibitory effects on isolated myometrium from preterm and term pregnant women.
Akerlund M; Bossmar T; Brouard R; Kostrzewska A; Laudanski T; Lemancewicz A; Serradeil-Le Gal C; Steinwall M
Br J Obstet Gynaecol; 1999 Oct; 106(10):1047-53. PubMed ID: 10519430
[TBL] [Abstract][Full Text] [Related]
10. Synthetic antagonists of the myometrial response to vasopressin and oxytocin.
Melin P; Trojnar J; Johansson B; Vilhardt H; Akerlund M
J Endocrinol; 1986 Oct; 111(1):125-31. PubMed ID: 3783079
[TBL] [Abstract][Full Text] [Related]
11. Lysine vasopressin-induced increases in porcine myometrial contractility and intracellular Ca2+ concentrations of myometrial cells: involvement of oxytocin receptors.
Yu H; Zhuge R; Hsu WH
Biol Reprod; 1995 Mar; 52(3):584-590. PubMed ID: 7756452
[TBL] [Abstract][Full Text] [Related]
12. Agonist and antagonist specificities of decidual prostaglandin-releasing oxytocin receptors and myometrial uterotonic oxytocin receptors in pregnant rats.
Chen DL; Chan WY; Manning M
J Reprod Fertil; 1994 Nov; 102(2):337-43. PubMed ID: 7861386
[TBL] [Abstract][Full Text] [Related]
13. 1-(1-[4-[(N-acetyl-4-piperidinyl)oxy]-2-methoxybenzoyl]piperidin-4- yl)-4H-3,1-benzoxazin-2(1H)-one (L-371,257): a new, orally bioavailable, non-peptide oxytocin antagonist.
Williams PD; Clineschmidt BV; Erb JM; Freidinger RM; Guidotti MT; Lis EV; Pawluczyk JM; Pettibone DJ; Reiss DR; Veber DF
J Med Chem; 1995 Nov; 38(23):4634-6. PubMed ID: 7473590
[No Abstract] [Full Text] [Related]
14. Vascular responses to vasopressin antagonists in man and rat.
Burrell LM; Phillips PA; Rolls KA; Buxton BF; Johnston CI; Liu JJ
Clin Sci (Lond); 1994 Oct; 87(4):389-95. PubMed ID: 7834989
[TBL] [Abstract][Full Text] [Related]
15. Antagonists for the human oxytocin receptor: an in vitro study.
Maggi M; Fantoni G; Baldi E; Cioni A; Rossi S; Vannelli GB; Melin P; Akerlund M; Serio M
J Reprod Fertil; 1994 Jul; 101(2):345-52. PubMed ID: 7932368
[TBL] [Abstract][Full Text] [Related]
16. A nonpeptide oxytocin receptor antagonist radioligand highly selective for human receptors.
Lemaire W; O'Brien JA; Burno M; Chaudhary AG; Dean DC; Williams PD; Freidinger RM; Pettibone DJ; Williams DL
Eur J Pharmacol; 2002 Aug; 450(1):19-28. PubMed ID: 12176104
[TBL] [Abstract][Full Text] [Related]
17. Oxytocin receptors and contractile response of the myometrium after long term infusion of prostaglandin F2 alpha, indomethacin, oxytocin and an oxytocin antagonist in rats.
Engstrøm T; Atke A; Vilhardt H
Regul Pept; 1988 Jan; 20(1):65-72. PubMed ID: 2832879
[TBL] [Abstract][Full Text] [Related]
18. [Arg8]vasopressin-induced responses of the human isolated coronary artery: effects of non-peptide receptor antagonists.
Bax WA; Van der Graaf PH; Stam WB; Bos E; Nisato D; Saxena PR
Eur J Pharmacol; 1995 Oct; 285(2):199-202. PubMed ID: 8566139
[TBL] [Abstract][Full Text] [Related]
19. Comparison of vasopressin and oxytocin receptors in the rat uterus and vascular tissue.
Anouar A; Clerget MS; Durroux T; Barberis C; Germain G
Eur J Pharmacol; 1996 Jul; 308(1):87-96. PubMed ID: 8836636
[TBL] [Abstract][Full Text] [Related]
20. Differences in the effects of vasopressin and oxytocin on rabbit myometrial activity and a possible mediation of prostaglandins.
Laudański T; Akerlund M; Batra S
J Reprod Fertil; 1977 Nov; 51(2):355-61. PubMed ID: 592288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
